JP2017501237A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017501237A5 JP2017501237A5 JP2016562466A JP2016562466A JP2017501237A5 JP 2017501237 A5 JP2017501237 A5 JP 2017501237A5 JP 2016562466 A JP2016562466 A JP 2016562466A JP 2016562466 A JP2016562466 A JP 2016562466A JP 2017501237 A5 JP2017501237 A5 JP 2017501237A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- alkyl
- cycloalkyl
- membered
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000217 alkyl group Chemical group 0.000 claims 63
- 229910052739 hydrogen Inorganic materials 0.000 claims 42
- 239000001257 hydrogen Substances 0.000 claims 40
- 125000005842 heteroatom Chemical group 0.000 claims 33
- 229910052760 oxygen Inorganic materials 0.000 claims 30
- 229910052717 sulfur Inorganic materials 0.000 claims 30
- 125000004432 carbon atom Chemical group C* 0.000 claims 27
- 125000000623 heterocyclic group Chemical group 0.000 claims 25
- 150000002431 hydrogen Chemical class 0.000 claims 25
- 125000005843 halogen group Chemical group 0.000 claims 22
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 15
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 15
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 claims 14
- 150000001875 compounds Chemical class 0.000 claims 14
- 150000003839 salts Chemical class 0.000 claims 13
- 229910052799 carbon Inorganic materials 0.000 claims 11
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 11
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 10
- 125000006376 (C3-C10) cycloalkyl group Chemical group 0.000 claims 8
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 7
- 125000002837 carbocyclic group Chemical group 0.000 claims 5
- 125000003341 7 membered heterocyclic group Chemical group 0.000 claims 3
- 125000003118 aryl group Chemical group 0.000 claims 3
- -1 substituted Chemical class 0.000 claims 3
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 208000030159 metabolic disease Diseases 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 2
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 2
- 208000023275 Autoimmune disease Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 125000003342 alkenyl group Chemical group 0.000 claims 1
- 208000026935 allergic disease Diseases 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000016097 disease of metabolism Diseases 0.000 claims 1
- 208000035475 disorder Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000004064 dysfunction Effects 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 125000003386 piperidinyl group Chemical group 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 claims 1
- 0 C*C(C)(C(F)(F)F)C(F)(F)F Chemical compound C*C(C)(C(F)(F)F)C(F)(F)F 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461923904P | 2014-01-06 | 2014-01-06 | |
| US61/923,904 | 2014-01-06 | ||
| PCT/US2015/010090 WO2015103510A1 (en) | 2014-01-06 | 2015-01-05 | Heterocyclic sulfone as ror-gamma modulators |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017501237A JP2017501237A (ja) | 2017-01-12 |
| JP2017501237A5 true JP2017501237A5 (en:Method) | 2018-01-25 |
| JP6476205B2 JP6476205B2 (ja) | 2019-02-27 |
Family
ID=52392247
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016562466A Expired - Fee Related JP6476205B2 (ja) | 2014-01-06 | 2015-01-05 | ＲＯＲγ修飾因子としてのヘテロ環式スルホン |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US9637455B2 (en:Method) |
| EP (1) | EP3092221B1 (en:Method) |
| JP (1) | JP6476205B2 (en:Method) |
| CN (1) | CN106061956B (en:Method) |
| ES (1) | ES2705400T3 (en:Method) |
| WO (1) | WO2015103510A1 (en:Method) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105705501B (zh) | 2013-09-09 | 2019-04-19 | 百时美施贵宝公司 | RORγ调节剂 |
| JP6397488B2 (ja) | 2013-09-20 | 2018-09-26 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | ＲＯＲγ調節因子 |
| JP6548664B2 (ja) * | 2014-01-06 | 2019-07-24 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | シクロヘキシルスルホンＲＯＲγ調節因子 |
| ES2713681T3 (es) | 2014-01-06 | 2019-05-23 | Bristol Myers Squibb Co | Moduladores de ROR gamma de sulfona carbocíclica |
| MX369347B (es) | 2014-01-06 | 2019-11-06 | Bristol Myers Squibb Co | Derivados de pirrolidinilsulfona y su uso como moduladores del receptor huerfano relacionado con retinoide gamma (ror gamma). |
| US9637455B2 (en) | 2014-01-06 | 2017-05-02 | Bristol-Myers Squibb Company | Heterocyclic sulfone RORγ modulators |
| JOP20200117A1 (ar) | 2014-10-30 | 2017-06-16 | Janssen Pharmaceutica Nv | كحولات ثلاثي فلوروميثيل كمُعدلات للمستقبل النووي جاما تي المرتبط بحمض الريتيونَويك ROR?t |
| CN107108598B (zh) | 2014-10-30 | 2020-11-17 | 詹森药业有限公司 | 作为Rorγt调节剂的噻唑 |
| SI3212642T1 (sl) | 2014-10-30 | 2020-01-31 | Janssen Pharmaceutica Nv | Amid substituirani tiazoli kot modulatorji RORGAMMAt |
| MX2017014189A (es) | 2015-05-07 | 2018-04-13 | Squibb Bristol Myers Co | Sulfonas triciclicas como moduladores del receptor huerfano relacionado con retinoide gamma (ror gamma). |
| TW201803869A (zh) | 2016-04-27 | 2018-02-01 | 健生藥品公司 | 作為ＲＯＲγＴ調節劑之６－胺基吡啶－３－基噻唑 |
| CN110278711B (zh) * | 2016-11-09 | 2023-12-15 | 百时美施贵宝公司 | 作为RORγ调节剂的三环砜 |
| CN112292373A (zh) | 2018-06-18 | 2021-01-29 | 詹森药业有限公司 | 作为RORγt的调节剂的吡啶基吡唑类 |
| WO2019244000A1 (en) | 2018-06-18 | 2019-12-26 | Janssen Pharmaceutica Nv | Phenyl and pyridinyl substituted imidazoles as modulators of roryt |
| CN112292183A (zh) | 2018-06-18 | 2021-01-29 | 詹森药业有限公司 | 作为RORγt的调节剂的6-氨基吡啶-3-基吡唑 |
| WO2019243999A1 (en) | 2018-06-18 | 2019-12-26 | Janssen Pharmaceutica Nv | Phenyl substituted pyrazoles as modulators of roryt |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE735866C (de) * | 1941-01-17 | 1943-06-11 | Ig Farbenindustrie Ag | Verfahren zur Darstellung von Aminoalkylsulfonverbindungen |
| US2802013A (en) * | 1954-02-12 | 1957-08-06 | Searle & Co | 2-(oxo and imino)-3-(phenyl and halophenyl)-tetrahydrofuransulfones and processes for the manufacture thereof |
| US3016403A (en) * | 1955-07-29 | 1962-01-09 | Searle & Co | 1-aryl-3-hydroxypropyl sulfones and processes |
| US2812330A (en) * | 1956-05-02 | 1957-11-05 | Searle & Co | Sulfone derivatives of 2, 6-piperidinedione |
| GB0108591D0 (en) * | 2001-04-05 | 2001-05-23 | Merck Sharp & Dohme | Therapeutic agents |
| TWI330176B (en) * | 2001-12-27 | 2010-09-11 | Daiichi Seiyaku Co | Inhibitor against the production and secretion of amyloid protein |
| WO2010019392A1 (en) * | 2008-08-13 | 2010-02-18 | Merck Sharp & Dohme Corp. | Purine derivatives for treatment of alzheimer's disease |
| US20130190356A1 (en) | 2011-12-22 | 2013-07-25 | Genentech, Inc. | Benzyl sulfonamide derivatives as rorc modulators |
| JP6236067B2 (ja) * | 2012-05-08 | 2017-11-22 | メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． | ＲＯＲγ活性を阻害し疾患を治療するための二環式スルホン化合物 |
| WO2014028669A1 (en) * | 2012-08-15 | 2014-02-20 | Biogen Idec Ma Inc. | Novel compounds for modulation of ror-gamma activity |
| WO2014062938A1 (en) | 2012-10-19 | 2014-04-24 | Bristol-Myers Squibb Company | Rory modulators |
| CN105705501B (zh) | 2013-09-09 | 2019-04-19 | 百时美施贵宝公司 | RORγ调节剂 |
| JP6397488B2 (ja) | 2013-09-20 | 2018-09-26 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | ＲＯＲγ調節因子 |
| ES2713681T3 (es) | 2014-01-06 | 2019-05-23 | Bristol Myers Squibb Co | Moduladores de ROR gamma de sulfona carbocíclica |
| JP6548664B2 (ja) | 2014-01-06 | 2019-07-24 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | シクロヘキシルスルホンＲＯＲγ調節因子 |
| US9637455B2 (en) | 2014-01-06 | 2017-05-02 | Bristol-Myers Squibb Company | Heterocyclic sulfone RORγ modulators |
| MX369347B (es) | 2014-01-06 | 2019-11-06 | Bristol Myers Squibb Co | Derivados de pirrolidinilsulfona y su uso como moduladores del receptor huerfano relacionado con retinoide gamma (ror gamma). |
-
2015
- 2015-01-05 US US15/109,727 patent/US9637455B2/en active Active
- 2015-01-05 EP EP15700818.6A patent/EP3092221B1/en not_active Not-in-force
- 2015-01-05 CN CN201580011973.8A patent/CN106061956B/zh not_active Expired - Fee Related
- 2015-01-05 WO PCT/US2015/010090 patent/WO2015103510A1/en not_active Ceased
- 2015-01-05 ES ES15700818T patent/ES2705400T3/es active Active
- 2015-01-05 JP JP2016562466A patent/JP6476205B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017501237A5 (en:Method) | ||
| JP2017508782A5 (en:Method) | ||
| JP2017509689A5 (en:Method) | ||
| JP2016506369A5 (en:Method) | ||
| RU2020110780A (ru) | Ингибитор fgfr и его медицинское применение | |
| JP2016514159A5 (en:Method) | ||
| JP2016503799A5 (en:Method) | ||
| JP2019501125A5 (en:Method) | ||
| JP2019535723A5 (en:Method) | ||
| JP2018515438A5 (en:Method) | ||
| JP2017501236A5 (en:Method) | ||
| JP2019524883A5 (en:Method) | ||
| JP2013537203A5 (en:Method) | ||
| JP2012041349A5 (en:Method) | ||
| JP2016532715A5 (en:Method) | ||
| JP2018516238A5 (en:Method) | ||
| JP2013502441A5 (en:Method) | ||
| JP2018516904A5 (en:Method) | ||
| RU2016134751A (ru) | Соединения | |
| JP2016516043A5 (en:Method) | ||
| JP2015522650A5 (en:Method) | ||
| RU2017144495A (ru) | Противогельминтные депсипептидные соединения | |
| JP2013544860A5 (en:Method) | ||
| JP2016531126A5 (en:Method) | ||
| JP2019504050A5 (en:Method) |